Ryan Tyner, PA
Physician Assistant · Memphis, TNNPI 1710583596
Payments from drug & device makers
Across 262 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$595
- Pfizer$523
- Philips North America LLC$498
- Boehringer Ingelheim$452
- Actelion Pharmaceuticals US, Inc.$444
- Johnson & Johnson$351
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,19599%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 44 | $595 |
| Pfizer | 30 | $523 |
| Philips North America LLC | 32 | $498 |
| Boehringer Ingelheim | 25 | $452 |
| Actelion Pharmaceuticals US, Inc. | 30 | $444 |
| Johnson & Johnson | 25 | $351 |
| Amarin Pharma, Inc. | 16 | $342 |
| Merck | 11 | $159 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $147 |
| Sanofi-aventis U.S. LLC | 6 | $117 |
| Amgen | 6 | $89 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $71 |
| AstraZeneca | 5 | $65 |
| Novo Nordisk | 3 | $61 |
| Bayer | 3 | $41 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Inspire Medical Systems, Inc. | 2 | $30 |
| Abiomed | 1 | $30 |
| Boston Scientific | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Silk Road Medical, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$4,216 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 75 | $69,574 |
| JardianceEmpagliflozin | 38 | $30,814 |
| XareltoRivaroxaban | 33 | $25,590 |
| EntrestoSacubitril/Valsartan | 21 | $25,350 |
| Repatha SureclickEvolocumab | 15 | $11,583 |
| FarxigaDapagliflozin Propanediol | 13 | $8,322 |
| Metoprolol Succinate | 197 | $2,330 |
| Rosuvastatin Calcium | 170 | $2,118 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 52 | $1,714 |
| Nebivolol Hcl | 16 | $1,618 |
| Prasugrel Hcl | 22 | $1,568 |
| Losartan Potassium | 120 | $1,299 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 55 | $1,257 |
| Atorvastatin Calcium | 108 | $1,118 |
| Amlodipine Besylate | 145 | $928 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $523 | $69,57475 claims |
| Boehringer IngelheimJardiance | $452 | $30,81438 claims |
| Johnson & JohnsonXarelto | $351 | $25,59033 claims |
| NovartisEntresto | $595 | $25,35021 claims |
| AstraZenecaFarxiga | $65 | $8,32213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Memphis
- Whitney GatewoodMemphis$104K
- Emily KunstmanMemphis$13K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.